From: The efficacy and safety of velagliflozin over 16 weeks as a treatment for insulin dysregulation in ponies
Wk-0
Wk-8
Wk-16
Wk-21
Control (n = 12)
5/12 (42%)
6/12 (50%)
8/12 (67%)
9/12 (75%)
Treated (n = 12)
2/12 (17%)
0/12 (0%)**